StockData
Zoetis Inc. logo

Zoetis Inc. (ZTS) stock

ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3046% below fair value
$83.48−0.91 (-1.08%)

Close on Nov 17, 2026Market cap $34.50BP/E 13.7Yield 2.43%

Zoetis operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Zoetis's operating cash flow for the twelve months ending Jun 30, 2026 was $2.84B, down 4.6% year over year. For fiscal 2025 it was $2.90B, down 1.7% from the year before. Over ten years it grew 15.9% a year on average. The highest annual figure on record is $2.95B in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.90B-1.7%
FY2024Dec 31, 2024$2.95B+25.5%
FY2023Dec 31, 2023$2.35B+23.1%
FY2022Dec 31, 2022$1.91B-13.6%
FY2021Dec 31, 2021$2.21B+4.1%
FY2020Dec 31, 2020$2.13B+18.4%
FY2019Dec 31, 2019$1.80B+0.3%
FY2018Dec 31, 2018$1.79B+33.0%
FY2017Dec 31, 2017$1.35B+88.8%
FY2016Dec 31, 2016$713.00M+7.4%
FY2015Dec 31, 2015$664.00M+6.1%
FY2014Dec 31, 2014$626.00M-8.1%
FY2013Dec 31, 2013$681.00M+50.0%
FY2012Dec 31, 2012$454.00M-8.7%
FY2011Dec 31, 2011$497.00M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$655.00M+8.3%
Q1 FY2026Mar 31, 2026$401.00M-22.1%
Q4 FY2025Dec 31, 2025$893.00M-1.3%
Q3 FY2025Sep 30, 2025$891.00M-6.3%
Q2 FY2025Jun 30, 2025$605.00M+20.5%
Q1 FY2025Mar 31, 2025$515.00M-13.4%
Q4 FY2024Dec 31, 2024$905.00M+0.9%
Q3 FY2024Sep 30, 2024$951.00M+31.4%
Q2 FY2024Jun 30, 2024$502.00M+174.3%
Q1 FY2024Mar 31, 2024$595.00M+8.4%
Q4 FY2023Dec 31, 2023$897.00M+21.1%
Q3 FY2023Sep 30, 2023$724.00M+37.6%
Q2 FY2023Jun 30, 2023$183.00M-45.5%
Q1 FY2023Mar 31, 2023$549.00M+77.7%
Q4 FY2022Dec 31, 2022$741.00M+9.1%
Q3 FY2022Sep 30, 2022$526.00M-19.4%
Q2 FY2022Jun 30, 2022$336.00M-30.1%
Q1 FY2022Mar 31, 2022$309.00M-22.8%
Q4 FY2021Dec 31, 2021$679.00M-5.4%
Q3 FY2021Sep 30, 2021$653.00M+16.2%
Q2 FY2021Jun 30, 2021$481.00M+9.8%
Q1 FY2021Mar 31, 2021$400.00M-2.0%
Q4 FY2020Dec 31, 2020$718.00M+23.4%
Q3 FY2020Sep 30, 2020$562.00M+11.1%
Q2 FY2020Jun 30, 2020$438.00M+37.7%
Q1 FY2020Mar 31, 2020$408.00M+4.9%
Q4 FY2019Dec 31, 2019$582.00M-0.3%
Q3 FY2019Sep 30, 2019$506.00M-8.0%
Q2 FY2019Jun 30, 2019$318.00M+19.1%
Q1 FY2019Mar 31, 2019$389.00M0.0%
Q4 FY2018Dec 31, 2018$584.00M-3.9%
Q3 FY2018Sep 30, 2018$550.00M+25.3%
Q2 FY2018Jun 30, 2018$267.00M+48.3%
Q1 FY2018Mar 31, 2018$389.00M+226.9%
Q4 FY2017Dec 31, 2017$608.00M+112.6%
Q3 FY2017Oct 1, 2017$439.00M+83.7%
Q2 FY2017Jul 2, 2017$180.00M–
Q1 FY2017Apr 2, 2017$119.00M–
Q4 FY2016Dec 31, 2016$286.00M–
Q3 FY2016Oct 2, 2016$239.00M–

More Zoetis figures

See a number that looks wrong?